GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Thanh Hoa Pharmaceutical Medical Material JSC (HSTC:DTH) » Definitions » EBIT

Thanh Hoa Pharmaceutical Medical Material JSC (HSTC:DTH) EBIT : ₫ Mil (TTM As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Thanh Hoa Pharmaceutical Medical Material JSC EBIT?

Thanh Hoa Pharmaceutical Medical Material JSC's earnings before interest and taxes (EBIT) for the six months ended in . 20 was ₫0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


Thanh Hoa Pharmaceutical Medical Material JSC EBIT Historical Data

The historical data trend for Thanh Hoa Pharmaceutical Medical Material JSC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thanh Hoa Pharmaceutical Medical Material JSC EBIT Chart

Thanh Hoa Pharmaceutical Medical Material JSC Annual Data
Trend
EBIT

Thanh Hoa Pharmaceutical Medical Material JSC Semi-Annual Data
EBIT

Competitive Comparison of Thanh Hoa Pharmaceutical Medical Material JSC's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Thanh Hoa Pharmaceutical Medical Material JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thanh Hoa Pharmaceutical Medical Material JSC's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Thanh Hoa Pharmaceutical Medical Material JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Thanh Hoa Pharmaceutical Medical Material JSC's EV-to-EBIT falls into.



Thanh Hoa Pharmaceutical Medical Material JSC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was ₫ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thanh Hoa Pharmaceutical Medical Material JSC  (HSTC:DTH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Thanh Hoa Pharmaceutical Medical Material JSC's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

Thanh Hoa Pharmaceutical Medical Material JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Thanh Hoa Pharmaceutical Medical Material JSC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/97073.873
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thanh Hoa Pharmaceutical Medical Material JSC EBIT Related Terms

Thank you for viewing the detailed overview of Thanh Hoa Pharmaceutical Medical Material JSC's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Thanh Hoa Pharmaceutical Medical Material JSC Business Description

Traded in Other Exchanges
N/A
Address
No. 232 Tran Phu, Lam Son Ward, Thanh Hoa Province, Thanh Hoa, VNM
Thanh Hoa Pharmaceutical Medical Material JSC is engaged in the field of manufacturing and trading pharmaceutical products.